Plain-English translation of NCT03627013 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study tests whether Custodiol-N, a newer organ preservation solution, works just as well as the standard Custodiol solution for keeping donated organs healthy before transplant. Organs need to be preserved carefully between the time they are removed from a donor and when they are transplanted into you. Researchers want to see if the new solution protects your organ just as well as the current standard.
During organ transplant, there is a period when the organ is outside the body and needs special care. Scientists want to find better ways to preserve organs so they work better after transplant and so more transplants can be successful.
You likely qualify if…
You likely don't qualify if…
You will receive your transplant using one of the two organ preservation solutions (assigned randomly). The organ preservation itself happens in the operating room as part of your standard transplant procedure—you won't notice a difference. After your transplant, you will have follow-up visits over 3 months (90 days) so doctors can monitor how well your new organ is working and check for any complications.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
Austria